BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML
Product details
Registration number: SIN16222P
Classification: Prescription Only
Active ingredients: Benzatropine mesilate
Strength: 2.0 mg/2ml
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: PHEBRA (SE ASIA) PTE. LTD.
ATC code: N04AC01
HSA approval date: 3 June 2021
Manufacturer(s): Phebra Pty Ltd
Manufacturing country/countries: AUSTRALIA
What are the HSA registration number and classification for BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16222P
Classification: Prescription Only
What active ingredients and strength are recorded for BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Benzatropine mesilate
Strength: 2.0 mg/2ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML?
According to the HSA dataset updated 7 August 2026:
Registrant: PHEBRA (SE ASIA) PTE. LTD.
Which manufacturers and countries are listed for BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Phebra Pty Ltd
Manufacturing country/countries: AUSTRALIA
Where can I look up BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16222P or the exact product name BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML. The general register link does not preselect this product.
What are the source dates for this BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BENZATROPINE PHEBRA SOLUTION FOR INJECTION 2 MG/2 ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16222P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)